metoclopramide has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metoclopramide treatment reduces murine and human LSCs in vitro and prolongs survival of chronic myeloid leukemia (CML) mice through downregulation of pathways related to stemness and proliferation in LSCs." | 1.62 | Metoclopramide treatment blocks CD93-signaling-mediated self-renewal of chronic myeloid leukemia stem cells. ( Albers, CE; Arambasic, M; Bachmann, C; Baerlocher, GM; Bürgin, DT; Hoppe, S; Kallen, NM; Lüthi, U; Ochsenbein, AF; Radpour, R; Riether, C; Schürch, CM, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riether, C | 1 |
| Radpour, R | 1 |
| Kallen, NM | 1 |
| Bürgin, DT | 1 |
| Bachmann, C | 1 |
| Schürch, CM | 1 |
| Lüthi, U | 1 |
| Arambasic, M | 1 |
| Hoppe, S | 1 |
| Albers, CE | 1 |
| Baerlocher, GM | 1 |
| Ochsenbein, AF | 1 |
1 other study available for metoclopramide and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Metoclopramide treatment blocks CD93-signaling-mediated self-renewal of chronic myeloid leukemia stem cells.
Topics: Animals; Dopamine D2 Receptor Antagonists; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; | 2021 |